Cargando…
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study
PURPOSE: Prostate specific antigen is not reliable in diagnosing prostate cancer (PCa), making the identification of novel, precise diagnostic biomarkers important. Since chemokines are associated with more aggressive disease and poor prognosis in diverse malignancies, we aimed to investigate the di...
Autores principales: | Tsaur, Igor, Noack, Anika, Makarevic, Jasmina, Oppermann, Elsie, Waaga-Gasser, Ana Maria, Gasser, Martin, Borgmann, Hendrik, Huesch, Tanja, Gust, Kilian M., Reiter, Michael, Schilling, David, Bartsch, Georg, Haferkamp, Axel, Blaheta, Roman A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398105/ https://www.ncbi.nlm.nih.gov/pubmed/25483747 http://dx.doi.org/10.4143/crt.2014.015 |
Ejemplares similares
-
Intensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells
por: Tsaur, Igor, et al.
Publicado: (2015) -
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis
por: Wedel, Steffen, et al.
Publicado: (2011) -
Feasibility, complications and oncologic results of a limited inguinal lymph node dissection in the management of penile cancer
por: Tsaur, Igor, et al.
Publicado: (2015) -
Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells
por: Tsaur, I, et al.
Publicado: (2012) -
sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients
por: Tsaur, Igor, et al.
Publicado: (2015)